Previous Article | Next Article 
Journal of Clinical Microbiology, November 2005, p. 5477-5482, Vol. 43, No. 11
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.11.5477-5482.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China
Min Zhang,1
Jun Yue,2
Yan-ping Yang,1
Hong-mei Zhang,1
Jian-qiang Lei,1
Rui-liang Jin,1
Xue-lian Zhang,1 and
Hong-hai Wang1*
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University,1
Shanghai Pneumology Hospital, Shanghai 200433, People's Republic of China2
Received 11 May 2005/
Returned for modification 16 June 2005/
Accepted 15 August 2005
Nine structural genes (furA, katG, inhA, kasA, Rv0340, iniB, iniA, iniC, and efpA) and two regulatory regions (the oxyR-ahpC intergenic region and the promoter of mabA-inhA) in 87 isoniazid (INH)-monoresistant and 50 INH-susceptible Mycobacterium tuberculosis isolates collected from five provinces of China were analyzed by sequencing. Eighty-two (94.3%) INH-resistant isolates had mutations in the katG gene, with the katG Ser315Thr mutation predominant (55.2%). No mutation at codon 463 of katG was detected among the 50 INH-susceptible isolates with different IS6110 fingerprints. In addition, there were 35 (40.2%) INH-resistant isolates that had a mutation at codon 463 of katG. Of the INH-resistant strains, 20 (23.0%) isolates harbored double mutations at two separate loci of katG. Mutations in the inhA promoter region occurred in 13 (14.9%) isolates; 4.6% of the isolates had inhA structural gene mutations, and 11.5% harbored mutations in the oxyR-ahpC intergenic region. Drug resistance-associated mutations were detected in the iniBAC region and efpA.
* Corresponding author. Mailing address: Institute of Genetics, Fudan University, 220 Handan Rd., Shanghai 200433, People's Republic of China. Phone: 86 21 65643777. Fax: 86 21 65648376. E-mail: hhwang{at}fudan.edu.cn.
Journal of Clinical Microbiology, November 2005, p. 5477-5482, Vol. 43, No. 11
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.11.5477-5482.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Abe, C., Kobayashi, I., Mitarai, S., Wada, M., Kawabe, Y., Takashima, T., Suzuki, K., Sng, L.-H., Wang, S., Htay, H. H., Ogata, H.
(2008). Biological and Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates with Low-Level Resistance to Isoniazid in Japan. J. Clin. Microbiol.
46: 2263-2268
[Abstract]
[Full Text]
-
Hillemann, D., Rusch-Gerdes, S., Richter, E.
(2007). Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. J. Clin. Microbiol.
45: 2635-2640
[Abstract]
[Full Text]
-
Brossier, F., Veziris, N., Truffot-Pernot, C., Jarlier, V., Sougakoff, W.
(2006). Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance.. J. Clin. Microbiol.
44: 3659-3664
[Abstract]
[Full Text]
-
Hazbon, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Leon, C. I., Bose, M., Chaves, F., Murray, M., Eisenach, K. D., Sifuentes-Osornio, J., Cave, M. D., Ponce de Leon, A., Alland, D.
(2006). Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis.. Antimicrob. Agents Chemother.
50: 2640-2649
[Abstract]
[Full Text]
-
Cavusoglu, C., Turhan, A., Akinci, P., Soyler, I.
(2006). Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolates.. J. Clin. Microbiol.
44: 2338-2342
[Abstract]
[Full Text]
Copyright © 2005 by the American Society for Microbiology. All rights reserved.